# Effects of Riboflavin on Faecalibacterium Prausnitzii and the Gut Microbiota

> **NCT02929459** · PHASE2 · COMPLETED · sponsor: **dsm-firmenich Switzerland AG** · enrollment: 105 (estimated)

## Conditions studied

- Gut Microbiota

## Interventions

- **DIETARY_SUPPLEMENT:** Riboflavin Dose 1
- **DIETARY_SUPPLEMENT:** Riboflavin Dose 2
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02929459
- **Lead sponsor:** dsm-firmenich Switzerland AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-01
- **Primary completion:** 2018-10-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 105 (ESTIMATED)
- **Last updated:** 2020-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02929459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02929459, "Effects of Riboflavin on Faecalibacterium Prausnitzii and the Gut Microbiota". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT02929459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*